Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit

New Kit Enables Automation of DNA Cloning on the BioXp® System Beginning from Linear DNA, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first […]

Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit Read More

Telstra Ventures-backed LambdaTest expands in the ANZ Region

LambdaTest provides an enterprise execution environment for organizations undergoing rapid digital transformation. Backed by Telstra Ventures, LambdaTest addresses the growing demand for secure and compliant test execution infrastructure within their private cloud. San Francisco, May 22, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading intelligent digital experience testing cloud, announced that its innovative solution for test execution […]

Telstra Ventures-backed LambdaTest expands in the ANZ Region Read More

Webull Celebrates Fifth Anniversary with the Launch of Webull 9.0 and Smart Advisor

Leading mobile brokerage continues to innovate to meet the evolving needs of retail investors NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Webull, a leading commission-free trading platform, is proudly celebrating its five-year anniversary. Since May 2018, Webull has offered its users professional level tools and analytics while creating an enjoyable, user-friendly investing experience. To […]

Webull Celebrates Fifth Anniversary with the Launch of Webull 9.0 and Smart Advisor Read More

Meltwater delivers the future of media, social and consumer intelligence through its industry-leading AI engine and ChatGPT integration

Meltwater expands on 20 years of robust AI capabilities with integration of OpenAI models and advanced algorithms to deliver insights, moving away from the time and guesswork needed to make sense of billions of pieces of online data. SAN FRANCISCO, May 22, 2023 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer […]

Meltwater delivers the future of media, social and consumer intelligence through its industry-leading AI engine and ChatGPT integration Read More

Nutricosmetics Formulation Expert & Microbiome Author Joins Codex Labs Medical Advisory Board

San Jose, CA, May 22, 2023 (GLOBE NEWSWIRE) — Codex Labs, a Silicon Valley bio-skintech company, and Paula Simpson, nutricosmetics formulator, author and microbiome expert, recently announced the addition of Paula to the Codex Labs medical advisory board. “As we delve deeper into skin-gut-brain integrative wellness solutions, we are excited to find partners who are […]

Nutricosmetics Formulation Expert & Microbiome Author Joins Codex Labs Medical Advisory Board Read More

Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology

May 22, 2023 Amsterdam, the Netherlands and Nashville, TN, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Vanderbilt University Medical Center (VUMC), home to the top-ranked adult and pediatric hospitals in the Southeastern U.S., today announced a collaboration that aims to reduce the health system’s carbon footprint while […]

Philips and Vanderbilt University Medical Center unite to define roadmap for decarbonizing radiology Read More

AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema

Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., May 22, 2023 (GLOBE NEWSWIRE) — AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun a Phase 1 trial and completed dosing the first cohort of patients diagnosed with wet age-related macular degeneration (wAMD), and/or diabetic macular edema (DME). “We are very excited […]

AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema Read More

Bombardier Challenger 3500 Business Jet Makes European Debut at EBACE 2023

Bombardier’s Challenger 3500 Business Jet The Challenger 3500 business jet, which will be on display at the European airshow, offers customers in the region a preview of Bombardier’s eco-design vision The Challenger 3500 aircraft boasts the first eco app* solution available in business aviation, optimizing flight plans for a reduced environmental footprint Passengers benefit from […]

Bombardier Challenger 3500 Business Jet Makes European Debut at EBACE 2023 Read More

Bombardier Achieves Important Milestones on EcoJet Research Project, Continues Industry-Defining Work Toward Sustainable Aviation

Bombardier’s EcoJet Research Project Bombardier successfully completes initial flight testing phase on the EcoJet research project, using a model of a blended-wing-body aircraft. The subsequent phase of testing, focusing on flying a larger scaled model, is well underway. The EcoJet research project aims to develop and mature technologies to support a sustainable future for business […]

Bombardier Achieves Important Milestones on EcoJet Research Project, Continues Industry-Defining Work Toward Sustainable Aviation Read More

Bombardier’s Certified Pre-Owned Aircraft Program Continues to Flourish, Showcases Pristine Challenger 605 Aircraft at EBACE 2023

Bombardier’s Certified Pre-Owned Challenger 605 aircraft Bombardier’s CPO program has established a dynamic premium category for customers in the pre-owned business jet market Customer interest has been overwhelmingly positive with several aircraft in service worldwide CPO aircraft carry an exclusive one-year OEM warranty* and are selected by the team, inspected and updated with refurbished interiors, […]

Bombardier’s Certified Pre-Owned Aircraft Program Continues to Flourish, Showcases Pristine Challenger 605 Aircraft at EBACE 2023 Read More